α Smooth muscle actin positive stromal cells in gastric carcinoma

Journal of Clinical Pathology

Volumn 55, Issue 10, 2002, Pages 741-744

  Nakayama, H ^a   Enzan, H ^a   Miyazaki, E ^a   Toi, M ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; CALDESMON; CD34 ANTIGEN;

ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STROMA CELL;

EID: 0036775582     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.55.10.741     Document Type: Article

References (20)

1. Nakayama H, Enzan H, Miyazaki E, et al. Differential expression of CD34 in colorectal normal tissue, peritumoral inflammatory tissue, and tumour stroma. J Clin Pathol 2000;53;626-9.
2. Nakayama H, Enzan H, Miyazaki E, et al. CD34-positive stromal cells in gastric adenocarcinomas. J Clin Pathol 2001;54:846-8.
3. Miettinen M, Lindenmayer AE, Chaubal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens: evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 1994;7:82-90.
4. Sappino AP, Dietrich PY, Skalli O, et al. Colonic pericryptal fibroblasts. Differentiation pattern in embryogenesis and phenotypic modulation in epithelial proliferative lesions. Virchows Arch A Pathol Anat Histopathol 1989;415:551-7.
5. Nakayama H, Miyazaki E, Enzan H. Differential expression of high molecular weight caldesmon in colorectal pericryptal fibroblasts and tumor stroma. J Clin Pathol 1999;52;785-6.
6. Nakayama H, Enzan H, Miyazaki E, et al. The role of myofibroblasts at the tumor border of invasive colorectal adenocarcinomas. Jpn J Clin Oncol 1998;28:615-20.
7. Nakayama H, Enzan H, Miyazaki E, et al. Myofibroblasts at the tumor border of invasive gastric adenocarcinomas: with reference to tumor depth and histological type. Oncol Rep 2000;7:1011-15.
8. Lazard D, Sastre X, Frid MG, et al. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci U S A 1993;90:999-1003.
9. Schurich W, Seemayer TA, Gabbiani G. The myofibroblast; a quarter century after its discovery. Am J Surg Pathol 1998;22:141-7.
10. Halvorsen TB, Semin E. Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer. J Clin Pathol 1989;42:162-6.
11. Civin CI, Strauss LC, Brovall C, et al. Antigenic analysis of hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1 a cells. J Immunol 1984;133:157-65.
12. Dvorak HF. Tumor: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315:1650-9.
13. Abe R, Donnelly SC, Peng T, et al. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001;166:7556-62.
14. Chesney J, Metz C, Stavitsky AB, et al. Regulated production of type I collagen inflammatory cytokines by peripheral blood fibrocytes. J Immunol 1998;160:419-25.
15. Lauren P. The two main types of gastric carcinoma. Diffuse and so-called intestinal type carcinomas. Acta Pathol Microbiol Scand 1965;64:31-49.
16. Watanabe H, Jass JR, Sobin H, in collaboration with pathologists in eight countries. Histological typing of oesophageal and gastric tumors, 2nd ed, edited by the World Health Organization (WHO), Berlin, Heidelberg, Germany: Springer-Verlag, 1990.
17. Seemayer TA, Lagace R, Schurch W, et al. Myofibroblasts in the stroma of invasive and metastatic carcinoma. A possible host response to neoplasia. Am J Surg Pathol 1979;3:525-33.
18. Hewitt RE, Powe DG, Carter GI, et al. Desmoplasia and its relevance to colorectal tumor invasion. Int J Cancer 1993;53:62-9.
19. Yoshida K, Yokozaki H, Niimoto M, et al. Expression of TGF-beta and procollagen type I and type III in human gastric carcinomas. Int J Cancer 1989;44:394-8.
20. Wu MS, Wang HP, Lin CC, et al. Loss of imprinting and overexpression of IGF-2 gene in gastric adenocarcinoma. Cancer Lett 1997;120:9-14.